Cooper Investors offloads $41m of Incitec stock
Incitec Pivot says it will forge ahead with asset sales next year, while at the same time warning earnings will take a hit from investment in plant.
Victoria Business
Barefoot Investor: ‘How I took on the fake Scott Pape scammers’
Barefoot Investor tried to uncover Facebook’s fake Scott Pape scammers but it all descended into chaos with his wife away, the kids sick and German backpackers running his farm.
ANZ’s board ignored a very loud message on bonuses
Qantas, Woolworths and now ANZ have all found out the hard way. On reputation – you go up slowly but come down at high speed.
Mesoblast turns 10-bagger on FDA approval
The company has received US Food and Drug Administration approval for its drug Ryoncil, in a stunning turnaround from a year ago, when the same drug tanked the share price.
More Stories
Oil, debt and China: A trifecta of threats to global recovery
For Citi’s New York-based global economist, Nathan Sheets, the difference between a recovery and global recession are finely balanced.
Inflation outlook ‘well anchored’: RBA
A top Reserve Bank official gives a strong indication the central bank could be preparing the way for an interest rate cut.
Businesses’ late bill payments at their worst since Covid
Late payments by businesses are at their highest level since the depths of Covid-19, and it’s the hospitality and construction sectors faring worst.
Gupta looks to offshore hundreds of millions to save his empire
Hundreds of millions of dollars on the books of one of GFG Alliance’s Australian subsidiaries could be sheeted home to prop up the ailing parent company, which owes $950m to creditors.
Macquarie’s new lighthouse is all about the AI boom
Investment bank Macquarie wants to build another AirTrunk, and the infrastructure supporting the tech revolution sits at the heart of its plans.
Inside John Gillam’s renovation rescue at Lendlease
The former hardware boss believes Lendlease can get its glory back. This involves ‘the right kind’ of risk.
A bit ruff: No dog is worth $60k in vet fees
Scott Pape loves his new kelpie pup but there’s no way he’ll be forking out $60,000 in vet fees like one of his financially-strained, dog-obsessed Barefoot followers did.
How Rio’s powerplay is rewriting the rules of lithium
The mining giant’s $10bn bet has electrified the struggling industry. However, Rio will bring a different mindset to lithium.
Tech and resources high among this week’s experts’ share tips
Aussie mining, energy and technology stocks are on the radar of our share market tipsters. See their recommendations.
The best ETFs of the past five years
Exchange traded funds, which let investors buy into entire sectors or markets with just one transaction, are going from strength to strength. But some ETFs are stronger than others.
Original URL: https://www.themercury.com.au/business/victoria-business/page/23